Clinical Trials
29 trialsTissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
Predicting Disease Progression and/or Recurrence in Cancer
Massachusetts General Hospital
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
Map HPB
University of Nottingham
ARCBile
AstraZeneca
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
REVEAL-BTC
MedSIR
Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
Shanghai Zhongshan Hospital
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
CHA University
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
CHA University
TRACE-BTC
Aarhus University Hospital
A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy
Eisai Inc.
TOX-FRAIL
Ankara Etlik City Hospital
The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer
National Health Research Institutes, Taiwan
Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
AstraZeneca
FAPi-2
Tata Memorial Centre
Liver and Biliary Tumor Tissue Registry
Mayo Clinic
New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
The Study of Association of Helicobacter Infections in Biliary Tract Cancers
Institute of Liver and Biliary Sciences, India
Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes
Centre Hospitalier Universitaire de Nice
Imfinzi PMS
AstraZeneca
GENTIS
CHA University
POELH-III
Erasmus Medical Center
ctdna-GI
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
CHA University
BABEL
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
GERCOR - Multidisciplinary Oncology Cooperative Group
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
University of Washington